Barely Significant
← all excerpts

WZ66, a novel acetyl-CoA carboxylase inhibitor, alleviates nonalcoholic steatohepatitis (NASH) in mice.

Acta Pharmacol Sin · 2020 · PMC7468331 · PMID 31645659

Europe PMCDOI
1
hedged sentence
0.0728
closest p · 1.5× alpha
0.0728
boldest claim

The sentences

an increasing trendP = 0.0728so close (0.05 < p ≤ 0.1)
The TGs in plasma showed an increasing trend ( P = 0.0728) in WZ66-treated mice relative to control mice (Fig. 6b ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.